If you need more lookups,
subscriptions start at $34 USD/month.
Beth Mellen Location
Boston, MA, US
Beth Mellen Work
Chief Regulatory Officer @ (July 2025 - Present)
Vice President, Regulatory and Quality @ (September 2023 - July 2025)
Vice President, Global Regulatory Strategy @ (November 2020 - September 2023)
Executive Director, Global Regulatory Strategy @ (September 2019 - November 2020)
Senior Director, Global Regulatory Strategy @ (September 2013 - September 2019)
Director, Head of North America Regulatory Affairs @ (October 2010 - September 2013)
Associate Director, Head of Regulatory and Quality @ Syndax Pharmaceuticals (June 2007 - October 2010)
Senior Manger, Regulatory Affairs @ (January 2006 - January 2007)
Manager, Regulatory Affairs @ (January 2004 - January 2006)
Regulatory Affairs Specialist @ (January 2002 - January 2004)
Regulatory Affairs Associate @ (January 1999 - January 2002)
Associate @ GelTex (January 1998 - January 1999)
Beth Mellen Education
Simmons University
MBA (Entrepreneurship)
2004-2007
Massachusetts College of Pharmacy and Health Sciences
MS (Regulatory Affairs)
2002-2004
University of Massachusetts Amherst
BS (Animal Science)
1993-1997
Beth Mellen Skills
Biologics
Biotechnology
Clinical Trials
Companion Diagnostics
Diagnose
FDA
IND
Oncology
Pharmaceutical Industry
Pharmaceutics
Regulatory Affairs
Regulatory Submissions
Beth Mellen Summary
Beth Mellen, based in Boston, MA, US, is currently a Chief Regulatory Officer at Stoke Therapeutics. Beth Mellen brings experience from previous roles at Voyager Therapeutics, Inc., Vertex Pharmaceuticals and Takeda. Beth Mellen holds a 2004 - 2007 MBA in Entrepreneurship @ Simmons University. With a robust skill set that includes Biologics, Biotechnology, Clinical Trials, Companion Diagnostics, Diagnose and more. Beth Mellen has 2 emails on RocketReach.
Looking for a different Beth Mellen?
Find contact details for 700 million professionals.